This program is supported by an educational grant from Daiichi Sankyo, Inc. This activity is jointly provided by Global Education Group and Rockpointe Corporation.
This activity is certified for credit.
Thursday, September 5
Pain continues to be a significant public-health problem, affecting more than 100 million adults in the US. The presence of pain causes significant reductions in patient quality of life, along with significant economic issues. The use of narcotic medications for pain management has increased dramatically in the US over the past two decades, resulting in increased concerns of misuse and abuse. Due to these concerns, patients in need of opioid medications for relief of acute and chronic pain are often undertreated.
Abuse-deterrent formulations of opioid medications have been developed to make opioids more difficult to abuse and/or to reduce the level of euphoria a patient feels when the formulation is altered. Abuse-deterrent formulations can play a key role in optimizing the risk-benefit ratio of opioid analgesia.
"Manage Pain and Minimize Misuse/Abuse: Using Abuse-deterrent Opioids to Enhance Patient Quality of Life" will discuss the barriers preventing adequate pain management, describe the effective use of abuse-deterrent formulations of opioid medications in clinical practice, and increase clinician awareness of patient engagement tools to optimize care.
At the conclusion of this activity, participants should be able to:
- Recognize clinician- and patient-related barriers that contribute to inadequate pain management
- Describe how to effectively utilize abuse-deterrent opioids to manage patients with acute and chronic pain
- Apply patient-engagement tools to enhance the care of patients with acute and chronic pain
Jeffrey Fudin, PharmD, FCCP, FASHP, FFSMB
Jeffrey Gudin, MD
Coffee will be served.
Pre-event Registration Website